Bluegrass Vascular Technologies Company Profile
Founded in 2011 and based in Lexington, Ky., Bluegrass Vascular Technologies is a medical technology company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. The companyâs initial product offering is the Surfacer⢠Inside-Out Access Catheter System, a proprietary instrumentation set that allows physicians to perform a novel âinside-outâ approach to gaining venous access. For more information, please visit www.bluegrassvascular.com.
News Articles
Bluegrass Family Health Announces Bluegrass SelectRx
Lexington, KY, September 06, 2012 --(PR.com)-- Bluegrass Family Health (BFH) has appointed Express Scripts, Inc., one of the nation’s leading pharmaceutical benefit management companies, to del...
Vascular Care Center Now Open at HealthCrave
San Antonio, TX (PRWEB) May 04, 2013 HealthCrave Medical Centers has opened a Vascular Care Center to take care of all your aesthetic and vascular needs. Because aesthetic and vascular concerns are...
N.Y. facility adopts Toshiba's vascular X-ray systems
Kaleida Health's Gates Vascular Institute in Buffalo, N.Y., has deployed 14 Infinix-i vascular X-ray devices from Toshiba Ame -More-
Vascular raises $16M in series A
Vascular Pharmaceuticals Inc. (Chapel Hill, N.C.) raised $16 million in a series A round co-led by new investors Intersouth Partners and MPM Capital. Vascular is developing VPI-2690B, a humanized mAb...
FDA clears r4 Vascular Vector PTA balloon catheters
The US Food and Drug Administration (FDA) has cleared r4 Vascular's high pressure Vector percutaneous transluminal angioplasty (PTA) balloon catheters for treating vascular narrowings lesions and bloc...
State of glycocalyx barrier indicates vascular risk in dialysis patients
The glycocalyx barrier – a mesh of proteoglycans and associated glycosaminoglycans present on vascular endothelium – is impaired in patients with renal failure, probably contributing to their pred...
GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
Maastricht, The Netherlands (PRWEB) January 16, 2013 GlycoCheck B.V., a leading provider of imaging and measurement software of the endothelial glycocalyx layer, today announced a reseller partners...
Vascular access in haemodialysis: strengthening the Achilles' heel
Dialysis vascular access continues to be both a 'lifeline' and an 'Achilles' heel' for patients on haemodialysis. In this Review, the authors address some of the problems associated with vascular acce...
Drugs and Medications
Oxygen [Bluegrass Oxygen, Inc.]
Nicardipine hydrochloride [Sandoz Inc. ]
Rx only
Nicardipine hydrochloride [Sandoz Inc. ]
Rx only
Nicardipine hydrochloride [Emcure Pharmaceuticals Ltd.]
Rx only
Standardized grass pollen, bermuda grass [Jubilant HollisterStier LLC]
ALLERGENIC EXTRACTS STANDARDIZED GRASS POLLEN (glycerinated)
PubMed Articles
Soil alkalization is one of the most prominent adverse environmental factors limiting plant growth, while alkali stress affects amino acids and carbohydrates metabolism. The objective of this study wa...
The effects of pipeline construction and reclamation techniques on the restoration of rough fescue plant communities following pipeline construction in southwestern Alberta, Canada were evaluated afte...
Adjunctive use of the superficial femoral vein for vascular reconstructions.
Clinical Trials
Patient Comfort With Vascular Closure
The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...
Study to Evaluate Safety & Effectiveness of Vascular Sealant System
To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.
Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis.Resistin was shown to induce vascular endothelial dysfunction and vascular smooth muscle cell...
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)
The investigators' study has 4 primary objectives. Among patients undergoing noncardiac surgery the investigators will determine: (1) the incidence of major perioperative vascular events;...
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
The purpose of this study is to evaluate the efficacy of PDE-3 inhibitor, cilostazol, in prevention and treatment of vascular dementia, in those with brain white matter lesions and vascula...
Companies
Bluegrass Vascular Technologies
Founded in 2011 and based in Lexington, Ky., Bluegrass Vascular Technologies is a medical technology company dedicated to developing and commercializing life-saving devices and me...
At Bluegrass Orthopaedics we believe that comprehensive care of the musculoskeletal system is essential to positive feeling of health and well being. Our goal is to treat you with the highest standar...
LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...
The Foundation for Accelerated Vascular Research
The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...
More Information about "Bluegrass Vascular Technologies" on BioPortfolio
We have published hundreds of Bluegrass Vascular Technologies news stories on BioPortfolio along with dozens of Bluegrass Vascular Technologies Clinical Trials and PubMed Articles about Bluegrass Vascular Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bluegrass Vascular Technologies Companies in our database. You can also find out about relevant Bluegrass Vascular Technologies Drugs and Medications on this site too.
